Intercept Pharmaceuticals Inc (ICPT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10 HUDSON YARDS, 37TH FLOOR NEW YORK, NY 10001

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.

Data as of 2021-08-02 08:23:51 -0400
Market Cap573.716 Million Shares Outstanding33.201 Million Avg 30-day Volume479.07 Thousand
P/E Ratio-3.37222 Dividend Yield EPS-5.13
Price/Sales1.68 Debt to Equity-2.57 EBITDA-106.515 Million
Price to Book Value-2.82 Forward PE-0.12 Enterprise Value735.108 Million
Total Cash414.423 Million Current Debt145.281 Million Gross Profit337.005 Million
BETA1.01006 52-week High/Low55.59 / 13.88 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from ICPT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 4 (0.23%) 2 (0.12%) 100.0%
Funds Holding: 149 174 -14.37% 50 (2.93%) 56 (3.25%) -10.71%
13F shares: 24.483 Million 26.715 Million -8.35% 4.943 Million 5.318 Million -7.04%
% Ownership 74.1568 80.9734 -8.42% 14.9721 16.118 -7.11%
New Positions: 15 35 -57.14% 10 17 -41.18%
Increased Positions 40 57 -29.82% 10 18 -44.44%
Closed Positions 39 37 5.41% 16 15 6.67%
Reduced Positions 56 51 9.8% 26 15 73.33%
Total Calls 1.058 Million 1.378 Million -23.23% 266.115 Thousand 302.2 Thousand -11.94%
Total Puts 1.571 Million 1.906 Million -17.59% 1.132 Million 903 Thousand 25.38%
PUT/CALL Ratio 1.49 1.38 7.97% 4.25 2.99 42.14%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ICPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ICPT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PRUZANSKI MARK

  • Director
609,611 2021-07-30 9

DURSO JEROME BENEDICT PRESIDENT & CEO

  • Officer
  • Director
81,853 2021-07-01 8

FORD DAVID A CHIEF HUMAN RESOURCES OFFICER

  • Officer
23,619 2021-07-01 9

VENEZIA ROCCO CHIEF ACCOUNTING OFFICER

  • Officer
14,259 2021-07-01 3

SAIK ANDREW EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2021-06-21 2

BERREY M MICHELLE PRESIDENT, R&D AND CMO

  • Officer
0 2021-06-14 2

AKKARAJU SRINIVAS

  • Director
682,927 2021-05-27 2

FUNDARO PAOLO

  • Director
  • 10% Owner
4,040,146 2021-05-27 2

SBLENDORIO GLENN

  • Director
27,799 2021-05-27 1

BENATTI LUCA

  • Director
29,839 2021-05-27 1

SANTINI GINO

  • Director
27,997 2021-05-27 1

GOTTESDIENER KEITH MICHAEL

  • Director
29,071 2021-05-27 1

BRADBURY DANIEL

  • Director
35,712 2021-05-27 1

MILLER-RICH NANCY

  • Director
26,656 2021-05-27 1

ROSA-BJORKESON DAGMAR

  • Director
28,262 2021-05-27 2

RICHARDSON LINDA M EVP & CHIEF COMMERCIAL OFFICER

  • Officer
26,695 2021-05-15 3

CAWKWELL GAIL SVP, MED AFFAIRS, SAFETY & PV

  • Officer
32,553 2021-05-12 6

WEYER CHRISTIAN EVP, RESEARCH & DEVELOPMENT

  • Officer
27,341 2021-04-01 7

DEFRANCESCO LISA SVP, IR & CORP. AFFAIRS

  • Officer
11,592 2021-02-15 1

FREEDBERG JARED GENERAL COUNSEL AND SECRETARY

  • Officer
0 2021-02-01 2

KAPADIA SANDIP CFO AND TREASURER

  • Officer
40,964 2021-01-22 4

CAMPAGNA JASON CHIEF MEDICAL OFFICER

  • Officer
20,531 2021-01-22 5

BALL BRYAN CHIEF QUALITY OFFICER

  • Officer
0 2021-01-11 2

KIM RICHARD J PRESIDENT US COMM & STRAT MKTG

  • Officer
19,770 2020-12-31 2

SULLIVAN RYAN T GENERAL COUNSEL AND SECRETARY

  • Officer
24,708 2020-11-13 2

GENEXTRA S.P.A.

4,000,000 2020-08-13 1

MICHELI FRANCESCO

4,000,000 2020-08-13 1

BRIGHT LISA PRESIDENT, INTERNATIONAL

  • Officer
22,012 2020-07-01 0

WELCH DANIEL G

  • Director
8,060 2020-05-28 0

SHAPIRO DAVID CHIEF MEDICAL OFFICER

  • Officer
39,499 2019-05-01 0

BRIGHT LISA PRESIDENT, INTERNATIONAL

BRIGHT LISA PRESIDENT, INTERNATIONAL

  • Officer
18,807 2019-01-07 0

MCMINN RACHEL CHIEF STRATEGY OFFICER

  • Officer
16,875 2017-10-02 0

DUNCAN BARBARA GAYLE CHIEF ACCOUNTING OFFICER

  • Officer
30,661 2016-10-03 0

ADORINI LUCIANO SEE REMARKS

  • Officer
No longer subject to file 2016-02-01 0

VEITINGER KLAUS R DR

  • Director
2,816 2015-11-24 0

SILVERSTEIN JONATHAN

  • Director
1,121,583 2015-11-24 0

WILLIAMS NICOLE

  • Director
962 2015-11-20 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP IV LLC

ISALY SAMUEL D

  • Director
1,120,609 2015-07-17 0

REGAN DANIEL PAUL CHIEF COMMERCIAL OFFICER

  • Officer
1,264 2015-01-30 0

PATEL SANJ K

  • Director
452 2014-07-17 0

TALLARIGO LORENZO

  • Director
0 2014-07-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PRUZANSKI MARK - Director

2021-08-02 19:00:43 -0400 2021-07-30 F 3,817 $17.28 d 609,611 direct

PRUZANSKI MARK - Director

2021-08-02 19:00:43 -0400 2021-07-30 A 6,138 $17.28 a 613,428 direct

DURSO JEROME BENEDICT - Director - Officer PRESIDENT & CEO

2021-07-02 19:00:52 -0400 2021-07-01 F 289 $20.47 d 81,853 direct -0.3151 -7.9832 0.0 1 -7.9832 6

FORD DAVID A - Officer CHIEF HUMAN RESOURCES OFFICER

2021-07-02 19:01:00 -0400 2021-07-01 F 92 $20.47 d 23,619 direct -0.3151 -7.9832 0.0 1 -7.9832 6

VENEZIA ROCCO - Officer CHIEF ACCOUNTING OFFICER

2021-07-02 19:01:24 -0400 2021-07-01 F 30 $20.47 d 14,259 direct -0.3151 -7.9832 0.0 1 -7.9832 6

PRUZANSKI MARK - Director

2021-07-01 19:01:27 -0400 2021-06-30 F 3,816 $19.97 d 607,290 direct -4.7524 -10.6553 0.0 1 -10.6553 6

PRUZANSKI MARK - Director

2021-07-01 19:01:27 -0400 2021-06-30 A 6,136 $19.97 a 611,106 direct -4.7524 -10.6553 0.0 1 -10.6553 6

SAIK ANDREW - Officer EVP & CHIEF FINANCIAL OFFICER

2021-06-22 19:01:42 -0400 2021-06-21 A 52,156 a 52,156 direct 3.1761 -3.898 6.1598 3 -3.898 6

SAIK ANDREW - Officer EVP & CHIEF FINANCIAL OFFICER

2021-06-22 19:01:42 -0400 2021-06-21 A 72,540 a 72,540 direct

BERREY M MICHELLE - Officer PRESIDENT, R&D AND CMO

2021-06-15 19:01:34 -0400 2021-06-14 A 67,118 a 67,118 direct -0.4427 2.2135 -15.1992 8.5096 8 -19.1835 29

BERREY M MICHELLE - Officer PRESIDENT, R&D AND CMO

2021-06-15 19:01:34 -0400 2021-06-14 A 93,000 a 93,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 22:15:03 UTC -0.4014 0.4614 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 21:45:03 UTC -0.4014 0.4614 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 21:15:03 UTC -0.4014 0.4614 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 20:45:03 UTC -0.4014 0.4614 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 20:15:03 UTC -0.4014 0.4614 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 19:45:03 UTC -0.4014 0.4614 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 19:15:03 UTC -0.4014 0.4614 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 18:45:03 UTC -0.4009 0.4609 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 18:15:03 UTC -0.4009 0.4609 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 17:45:03 UTC -0.4009 0.4609 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 17:15:03 UTC -0.4009 0.4609 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 16:45:03 UTC -0.4025 0.4825 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 16:15:03 UTC -0.4025 0.4825 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 15:45:03 UTC -0.4025 0.4825 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 15:15:03 UTC -0.4025 0.4825 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 14:45:03 UTC -0.3937 0.4737 950000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 14:15:03 UTC -0.3937 0.4737 850000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 13:45:03 UTC -0.3937 0.4737 850000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 13:15:04 UTC -0.3937 0.4737 850000
INTERCEPT PHARMACEUTICALS IN ICPT 2021-08-02 12:45:03 UTC -0.3937 0.4737 850000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Multi-Strategy Alternative Fund ICPT -9.0 shares, $-373.14 2020-09-30 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio ICPT -976.0 shares, $-22526.08 2021-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund ICPT -1113.0 shares, $-25688.04 2021-03-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund ICPT -7066.0 shares, $-163083.28 2021-03-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund ICPT -22000.0 shares, $-435160.0 2021-04-30 N-PORT

Elevate your investments